GL1X · GenesisL1 explorer

MolNFT v1 · #131800 · protein

Pandda analysis group deposition -- crystal structure of PTP1B in complex with COMPOUND_FMSOA000272B

5QF1 · Tyrosine-protein phosphatase non-receptor type 1: “Pandda analysis group deposition -- crystal structure of PTP1B in complex with COMPOUND_FMSOA000272B”. X-ray diffraction, 1 ligand (JMD), 1 pocket (best druggability 0.46). MolNFT…

PDB
5QF1
Type
protein
Length
282 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 1
EC
3.1.3.48
UniProt
P18031
Ligands
JMD
Pockets
1 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48)protein28234% helix, 23% strandP18031

Ligands and binding sites

  • JMD · 4-(2-hydroxyethyl)benzonitrile · ligand · chains A
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11430.460.7724empty

Compared structures

  • 5QF1 · PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.